Friday 6 November 2026 Export MDT’s income statement to Excel — free account

Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025.

Revenue: +13.7%
EPS: +42.0%
Free cash flow: +120.9%
Total debt: −1.59%

Quarter to July 2026, against a year earlier

101.77 3.07 −2.93%

Follow MDT

Alert me

Market cap: $134.1B
P/E: 25.6×
Fwd P/E: 20.8×
Dividend yield: 2.74%
F-score: 7/9
Altman Z: 2.73
Beneish M: −2.58
Dividend safety: 61/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Medtronic PLC (MDT) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Medtronic PLC (MDT) trades at a price to free cash flow of 21.8×. Over the past ten years it has ranged from 12.5× (January 2015) to 38.2× (April 2021); the current reading is higher than 38% of that period. That is below the Medical Devices industry median of 28.8× and in line with the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/MDT/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Medtronic PLC price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/MDT/metrics/price-to-free-cash-flow">Medtronic PLC (MDT) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2026	19.1×	(8.98%)
FY2025	21.0×	2.58%
FY2024	20.5×	(22.19%)
FY2023	26.3×	13.68%
FY2022	23.2×	(35.74%)
FY2021	36.0×	65.80%
FY2020	21.7×	6.78%
FY2019	20.4×	(32.28%)
FY2018	30.1×	46.48%
FY2017	20.5×	(23.45%)

Period	Price to free cash flow	Change
Jul 2026	17.8×	(6.83%)
Apr 2026	19.1×	(21.45%)
Jan 2026	24.4×	9.02%
Oct 2025	22.3×	2.41%
43 more quarters	Free account

Against its own ten years

Low 12.5× High 38.2×

Ten-year median 22.9×

Current reading's percentile 38

Company	Price to free cash flow
PHG Koninklijke Philips N.V. compare	14.1×
BSX Boston Scientific Corporation compare	19.3×
GEHC GE HealthCare Technologies Inc. compare	19.9×
MDT Medtronic PLC	21.8×
ABT Abbott Laboratories compare	25.2×
STE STERIS plc compare	26.4×
DXCM DexCom, Inc. compare	28.8×
SYK Stryker Corporation compare	28.9×
EW Edwards Lifesciences Corporation compare	41.5×
Medical Devices industry median	28.8×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Medtronic PLC (MDT) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on MDT

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on MDT

Stockrow Weekly